High-dose intravenous immunoglobulin in the management of myasthenia gravis
- 1 July 1986
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 146 (7), 1365-1368
- https://doi.org/10.1001/archinte.146.7.1365
Abstract
Research from JAMA Internal Medicine — High-Dose Intravenous Immunoglobulin in the Management of Myasthenia GravisThis publication has 13 references indexed in Scilit:
- Efficacy of Intravenous Immunoglobulin in Primary Humoral Immunodeficiency DiseaseAnnals of Internal Medicine, 1984
- ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULINThe Lancet, 1984
- Long‐term corticosteriod treatment of myasthenia gravis: Report of 116 PatientsAnnals of Neurology, 1984
- INTRAVENOUS GAMMA-GLOBULIN TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA1983
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982
- Circulating immune complexes in myasthenia gravis: a study in relation to thymectomy, clinical severity and thymus histology.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- Loss of Fc receptor activity after culture of human monocytes on surface-bound immune complexes. Mediation by cyclic nucleotides.The Journal of Experimental Medicine, 1980
- Passively transferred experimental autoimmune myasthenia gravisNeurology, 1979
- Myasthenia GravisNew England Journal of Medicine, 1978
- Antibody to acetylcholine receptor in myasthenia gravisNeurology, 1976